FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020140879> ?p ?o ?g. }

• W2020140879 endingPage "1315" @default.
• W2020140879 startingPage "1310" @default.
• W2020140879 abstract "Objective: Acute renal failure is associated with significant morbidity and mortality rates. Need for dialysis is an independent risk factor for early mortality after complicated cardiac surgery. Human atrial natriuretic peptide (h-ANP) is a potent endogenous natriuretic and diuretic substance. Exogenous administration of h-ANP increases glomerular filtration rate and renal blood flow in clinical acute renal failure. We have studied the effects of h-ANP on renal outcome in ischemic acute renal failure. Design: A prospective, double-blind, randomized, placebo-controlled study. Setting: Cardiothoracic intensive care units of two tertiary care centers. Patients: Sixty-one patients with normal preoperative renal function suffering from postcardiac surgical heart failure requiring significant inotropic and vasoactive support. Interventions: The patients were randomized to receive a continuous infusion of either recombinant h-ANP (50 ng·kg−1·min−1) or placebo when serum creatinine increased by >50% from baseline. The treatment with h-ANP/placebo continued until serum creatinine decreased below the trigger value for inclusion or the patients fulfilled predefined criteria for dialysis. Measurements and Main Results: The primary outcome variable was dialysis on or before day 21 after the start of treatment. Secondary renal outcome variables were dialysis-free survival at day 21 and creatinine clearance. Twenty-nine patients were assigned h-ANP and 30 placebo. Six (21%) patients in the h-ANP group compared with 14 (47%) in the placebo group needed dialysis before or at day 21 (hazard ratio, 0.28; 95% confidence interval, 0.10–0.73; p = .009). Eight (28%) patients in the h-ANP group compared with 17 (57%) in the placebo group suffered from the combined end point dialysis or death before or at day 21 (hazard ratio, 0.35; 95% confidence interval, 0.14–0.82; p = .017). h-ANP improved creatinine clearance in contrast to placebo (p = .040). Conclusions: Infusion of h-ANP at a rate of 50 ng·kg−1·min−1 enhances renal excretory function, decreases the probability of dialysis, and improves dialysis-free survival in early, ischemic acute renal dysfunction after complicated cardiac surgery." @default.
• W2020140879 created "2016-06-24" @default.
• W2020140879 creator A5001137494 @default.
• W2020140879 creator A5027206436 @default.
• W2020140879 creator A5034585262 @default.
• W2020140879 creator A5051098405 @default.
• W2020140879 creator A5054593552 @default.
• W2020140879 date "2004-06-01" @default.
• W2020140879 modified "2023-10-17" @default.
• W2020140879 title "Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial*" @default.
• W2020140879 cites W1967135033 @default.
• W2020140879 cites W1967237457 @default.
• W2020140879 cites W1982628508 @default.
• W2020140879 cites W1985726091 @default.
• W2020140879 cites W1990838314 @default.
• W2020140879 cites W2005934342 @default.
• W2020140879 cites W2012029042 @default.
• W2020140879 cites W2018964430 @default.
• W2020140879 cites W2026682710 @default.
• W2020140879 cites W2026708075 @default.
• W2020140879 cites W2038044430 @default.
• W2020140879 cites W2038390022 @default.
• W2020140879 cites W2043132544 @default.
• W2020140879 cites W2057571412 @default.
• W2020140879 cites W2077828613 @default.
• W2020140879 cites W2096885619 @default.
• W2020140879 cites W2097188437 @default.
• W2020140879 cites W2099280799 @default.
• W2020140879 cites W2151435234 @default.
• W2020140879 cites W2172136015 @default.
• W2020140879 cites W2172702936 @default.
• W2020140879 cites W2242506327 @default.
• W2020140879 cites W2321262365 @default.
• W2020140879 doi "https://doi.org/10.1097/01.ccm.0000128560.57111.cd" @default.
• W2020140879 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15187512" @default.
• W2020140879 hasPublicationYear "2004" @default.
• W2020140879 type Work @default.
• W2020140879 sameAs 2020140879 @default.
• W2020140879 citedByCount "218" @default.
• W2020140879 countsByYear W20201408792012 @default.
• W2020140879 countsByYear W20201408792013 @default.
• W2020140879 countsByYear W20201408792014 @default.
• W2020140879 countsByYear W20201408792015 @default.
• W2020140879 countsByYear W20201408792016 @default.
• W2020140879 countsByYear W20201408792017 @default.
• W2020140879 countsByYear W20201408792018 @default.
• W2020140879 countsByYear W20201408792019 @default.
• W2020140879 countsByYear W20201408792020 @default.
• W2020140879 countsByYear W20201408792021 @default.
• W2020140879 countsByYear W20201408792022 @default.
• W2020140879 countsByYear W20201408792023 @default.
• W2020140879 crossrefType "journal-article" @default.
• W2020140879 hasAuthorship W2020140879A5001137494 @default.
• W2020140879 hasAuthorship W2020140879A5027206436 @default.
• W2020140879 hasAuthorship W2020140879A5034585262 @default.
• W2020140879 hasAuthorship W2020140879A5051098405 @default.
• W2020140879 hasAuthorship W2020140879A5054593552 @default.
• W2020140879 hasConcept C126322002 @default.
• W2020140879 hasConcept C142724271 @default.
• W2020140879 hasConcept C159641895 @default.
• W2020140879 hasConcept C164705383 @default.
• W2020140879 hasConcept C204787440 @default.
• W2020140879 hasConcept C207103383 @default.
• W2020140879 hasConcept C27081682 @default.
• W2020140879 hasConcept C2778069365 @default.
• W2020140879 hasConcept C2778198053 @default.
• W2020140879 hasConcept C2779978075 @default.
• W2020140879 hasConcept C2780306776 @default.
• W2020140879 hasConcept C2780472472 @default.
• W2020140879 hasConcept C44249647 @default.
• W2020140879 hasConcept C54847362 @default.
• W2020140879 hasConcept C71924100 @default.
• W2020140879 hasConceptScore W2020140879C126322002 @default.
• W2020140879 hasConceptScore W2020140879C142724271 @default.
• W2020140879 hasConceptScore W2020140879C159641895 @default.
• W2020140879 hasConceptScore W2020140879C164705383 @default.
• W2020140879 hasConceptScore W2020140879C204787440 @default.
• W2020140879 hasConceptScore W2020140879C207103383 @default.
• W2020140879 hasConceptScore W2020140879C27081682 @default.
• W2020140879 hasConceptScore W2020140879C2778069365 @default.
• W2020140879 hasConceptScore W2020140879C2778198053 @default.
• W2020140879 hasConceptScore W2020140879C2779978075 @default.
• W2020140879 hasConceptScore W2020140879C2780306776 @default.
• W2020140879 hasConceptScore W2020140879C2780472472 @default.
• W2020140879 hasConceptScore W2020140879C44249647 @default.
• W2020140879 hasConceptScore W2020140879C54847362 @default.
• W2020140879 hasConceptScore W2020140879C71924100 @default.
• W2020140879 hasIssue "6" @default.
• W2020140879 hasLocation W20201408791 @default.
• W2020140879 hasLocation W20201408792 @default.
• W2020140879 hasOpenAccess W2020140879 @default.
• W2020140879 hasPrimaryLocation W20201408791 @default.
• W2020140879 hasRelatedWork W2012022070 @default.
• W2020140879 hasRelatedWork W2057668392 @default.
• W2020140879 hasRelatedWork W2075783751 @default.
• W2020140879 hasRelatedWork W2089758678 @default.
• W2020140879 hasRelatedWork W2091664778 @default.
• W2020140879 hasRelatedWork W2093397804 @default.

• next